Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
1.130
-0.020 (-1.74%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $26.66 million as of August 26, 2026. Its market cap has decreased by -58.24% in one year.
Market Cap
26.66M
Enterprise Value
2.53M
1-Year Change
-58.24%
Ranking
Category
Stock Price
$1.13
ChartMarket Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $26.66M, a decrease of -87.23%. That is a compound annual growth rate of -35.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 26.66M | -23.65% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GridAI Technologies | 29.03M |
| BeyondSpring | 28.78M |
| Lantern Pharma | 28.13M |
| NextCure | 27.58M |
| CEL-SCI | 26.82M |
| Atossa Therapeutics | 26.59M |
| Evaxion | 26.52M |
| Enlivex | 26.40M |